Official U.S. tally of new cases may be declining, but at-home testing obscures data; Novavax opens trial of vaccine for very young children
The daily average of new U.S. cases may have started to decline based on official…
Read MoreThe daily average of new U.S. cases may have started to decline based on official…
Read MoreModerna MRNA, +3.81% and Pfizer PFE, -0.41% have not yet started clinical trials for the…
Read MoreResearch published Tuesday by the journal Science offers more evidence that the coronavirus pandemic that…
Read MoreResearch published Tuesday by the journal Science offers more evidence that the coronavirus pandemic that…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreU.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read MoreA new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read MoreA new, highly infectious subvariant of omicron is raising concerns among scientists and health experts…
Read MoreWhile the daily average of new COVID-19 cases have settled back into a low-100K range…
Read MoreThe U.S. is gearing up for another wave of COVID-19 infections in the fall and…
Read More